Development of a parathyroid hormone-controlled release system as a potential surgical treatment for hypoparathyroidism-Reference-Cited by-同舟云学术

Development of a parathyroid hormone-controlled release system as a potential surgical treatment for hypoparathyroidism

Published:2005-01 Issue:1 Volume:40 Page:81-85
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Anthony Tiffany,Fong Peter,Goyal Amit,Saltzman W. Mark,Moss R. Lawrence,Breuer Christopher

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference28 articles.

1. Hypoparathyroidism and 22q11 deletion syndrome;Taylor;Arch. Dis. Child.,2003

2. Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome;Cuneo;Am. J. Med. Genet.,1997

3. Parathyroid infusion test in children and adolescents;Hochberg;Miner. Electrolyte Metab.,1984

4. Endocrinology and metabolism;Felig,2001

5. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25 dihydroxyvitamin D3;Chan;Pediatrics,1983

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naringin as Sustained Delivery Nanoparticles Ameliorates the Anti-inflammatory Activity in a Freund’s Complete Adjuvant-Induced Arthritis Model;ACS Omega;2021-10-22

2. Advances in intravesical drug delivery systems to treat bladder cancer;International Journal of Pharmaceutics;2017-10

3. Application of sustained release microsphere in hypoparathyroidism after thyroid surgery;BIO Web of Conferences;2017

4. Surface-Modified Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer;Molecular Cancer Therapeutics;2013-11-12

5. Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer;Nanomedicine: Nanotechnology, Biology and Medicine;2013-11